Sarepta (SRPT) Trades Higher on Eteplirsen Phase II Update, Analyst Comments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 49.46 -0.05 (0.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.51 | 52 Week High | $45.58 | |||
| Open | $49.44 | 52 Week Low | $37.82 | |||
| Day High | $49.81 | P/E | N/A | |||
| Day Low | $49.26 | EPS | $0.00 | |||
| Volume | 5,373,064 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.73 +0.63 (3.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.10 | 52 Week High | $63.73 | |||
| Open | $17.25 | 52 Week Low | $8.00 | |||
| Day High | $17.83 | P/E | N/A | |||
| Day Low | $17.12 | EPS | $-5.69 | |||
| Volume | 2,329,413 | |||||
